Cell Therapy Technologies Market Report 2026

Cell Therapy Technologies Market Overview

• Cell Therapy Technologies market size has reached to $5.67 billion in 2025 • Expected to grow to $11.35 billion in 2030 at a compound annual growth rate (CAGR) of 14.8% • Growth Driver: Rising Cancer Prevalence Drives Growth In The Cell Therapy Technologies Market • Market Trend: Companies Pioneer Advanced Technologies In The Cell Therapy Technologies Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Therapy Technologies Market?

Cell therapy is a type of treatment in which active cells are injected into a patient's body to treat certain disorders. This therapy seeks to treat diseases by altering certain sets of cells. In this technique, cells that originate from the patient or a donor are modified outside the body and then injected into the patient. The main types of products in cell therapy technologies are consumables, equipment, systems & software. Consumables are goods that are intended to be used up or depleted in the course of normal use. They are applied in different types of cells, including T-cells, stem cells, and other cells. The processes involved in cell therapy technologies include cell processing, cell preservation, distribution, handling, process monitoring, and quality control. Cell therapy technologies are used in various sectors, including life science companies, research institutes, and cell banks

What Is The Cell Therapy Technologies Market Growth Forecast?

The cell therapy technologies market size is expected to see rapid growth in the next few years. It will grow to $11.35 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing commercialization of cell therapies, rising investments in regenerative medicine, expansion of point-of-care cell therapy systems, growing demand for automated manufacturing workflows, increasing regulatory focus on process consistency. Major trends in the forecast period include increasing adoption of closed-system cell processing platforms, rising use of automated cell culture systems, growing demand for scalable cell therapy manufacturing, expansion of process monitoring and quality control tools, enhanced focus on standardized cell handling.

Global Cell Therapy Technologies Market Segmentation

1) By Product: Consumables, Equipment, Systems And Software 2) By Cell Type: T-Cells, Stem Cells, Other Cell Types 3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control 4) By End User: Life Science Companies, Research Institutes And Cell Banks Subsegments: 1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials 2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators 3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

What Is The Driver Of The Cell Therapy Technologies Market?

The increased prevalence of cancer is expected to drive the growth of the cell therapy technologies market during the forecast period. Cell therapy uses living cells as drugs to treat disease. When used to treat cancer, cell therapy takes advantage of the immune system’s intrinsic ability to seek out and destroy abnormal cells in the body. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased to 2,001,140 compared to 1,958,310 in 2023, reflecting a growth of 2.19%. Therefore, the increase in the number of cases of cancer is expected to contribute to the growth of the cell therapy technologies industry going forward.

Key Players In The Global Cell Therapy Technologies Market

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies

Global Cell Therapy Technologies Market Trends and Insights

Major companies operating in the cell therapy market are focusing on developing technological advancements such as automated manufacturing platforms to improve scalability, reproducibility, and efficiency in producing cell-based therapies. Automated cell therapy technologies integrate robotics, process monitoring, and closed-system manufacturing to streamline production while maintaining cell quality and regulatory compliance. For instance, in 2025, Limula, a US-based cell therapy company, launched an automated cell therapy platform designed to accelerate cell manufacturing, reduce manual intervention, and enhance the consistency and safety of therapeutic cell products. The launch of this platform marks a significant step toward commercial-scale cell therapy production, enabling faster translation from research to clinical application.

What Are Latest Mergers And Acquisitions In The Cell Therapy Technologies Market?

In October 2025, Bristol Myers Squibb, a US-based biopharmaceutical company, acquired Orbital, for $1.5 billion. With this acquisition, Bristol Myers Squibb aims to expand its cell therapy pipeline, accelerate the development of next-generation cellular therapies, strengthen its position in the oncology and immunotherapy markets, and enhance long-term growth opportunities in advanced biopharmaceuticals. Orbital Therapeutics is a US-based cell therapy biotechnology company specializes in developing innovative cell therapy platforms for treating complex diseases.

Regional Outlook

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Therapy Technologies Market?

The cell therapy market consists of sales of cell therapy technologies that are medicinal solutions used for developing and improving cell therapy, such as cell processing, cell banking, and point-of-care technologies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Therapy Technologies Market Report 2026?

The cell therapy technologies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy technologies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.